Quinlivan EB - Search Results

1

RAZ, an Epstein-Barr virus transdominant repressor that modulates the viral reactivation mechanism.

Furnari FB, Zacny V, Quinlivan EB, Kenney S, Pagano JS. Furnari FB, et al. Among authors: quinlivan eb. J Virol. 1994 Mar;68(3):1827-36. doi: 10.1128/JVI.68.3.1827-1836.1994. J Virol. 1994. PMID: 8107245 Free PMC article.

2

The cellular oncogene c-myb can interact synergistically with the Epstein-Barr virus BZLF1 transactivator in lymphoid cells.

Kenney SC, Holley-Guthrie E, Quinlivan EB, Gutsch D, Zhang Q, Bender T, Giot JF, Sergeant A. Kenney SC, et al. Among authors: quinlivan eb. Mol Cell Biol. 1992 Jan;12(1):136-46. doi: 10.1128/mcb.12.1.136-146.1992. Mol Cell Biol. 1992. PMID: 1309587 Free PMC article.

3

The Epstein-Barr virus BRLF1 immediate-early gene product transactivates the human immunodeficiency virus type 1 long terminal repeat by a mechanism which is enhancer independent.

Quinlivan EB, Holley-Guthrie E, Mar EC, Smith MS, Kenney S. Quinlivan EB, et al. J Virol. 1990 Apr;64(4):1817-20. doi: 10.1128/JVI.64.4.1817-1820.1990. J Virol. 1990. PMID: 2157062 Free PMC article.

4

The Epstein-Barr virus (EBV) BMRF1 promoter for early antigen (EA-D) is regulated by the EBV transactivators, BRLF1 and BZLF1, in a cell-specific manner.

Holley-Guthrie EA, Quinlivan EB, Mar EC, Kenney S. Holley-Guthrie EA, et al. Among authors: quinlivan eb. J Virol. 1990 Aug;64(8):3753-9. doi: 10.1128/JVI.64.8.3753-3759.1990. J Virol. 1990. PMID: 2164595 Free PMC article.

5

Direct BRLF1 binding is required for cooperative BZLF1/BRLF1 activation of the Epstein-Barr virus early promoter, BMRF1.

Quinlivan EB, Holley-Guthrie EA, Norris M, Gutsch D, Bachenheimer SL, Kenney SC. Quinlivan EB, et al. Nucleic Acids Res. 1993 Jul 11;21(14):1999-2007. doi: 10.1093/nar/21.8.1999. Nucleic Acids Res. 1993. PMID: 8393562 Free PMC article.

6

Subclinical central nervous system infection with JC virus in patients with AIDS.

Quinlivan EB, Norris M, Bouldin TW, Suzuki K, Meeker R, Smith MS, Hall C, Kenney S. Quinlivan EB, et al. J Infect Dis. 1992 Jul;166(1):80-5. doi: 10.1093/infdis/166.1.80. J Infect Dis. 1992. PMID: 1318912

7

Gene expression from the ORF50/K8 region of Kaposi's sarcoma-associated herpesvirus.

Seaman WT, Ye D, Wang RX, Hale EE, Weisse M, Quinlivan EB. Seaman WT, et al. Among authors: quinlivan eb. Virology. 1999 Oct 25;263(2):436-49. doi: 10.1006/viro.1999.9963. Virology. 1999. PMID: 10544116 Free article.

8

Lytic switch protein (ORF50) response element in the Kaposi's sarcoma-associated herpesvirus K8 promoter is located within but does not require a palindromic structure.

Seaman WT, Quinlivan EB. Seaman WT, et al. Among authors: quinlivan eb. Virology. 2003 May 25;310(1):72-84. doi: 10.1016/s0042-6822(03)00095-3. Virology. 2003. PMID: 12788632 Free article.

9

Epstein-Barr virus and human herpesvirus 8 prevalence in human immunodeficiency virus-associated oral mucosal lesions.

Webster-Cyriaque J, Edwards RH, Quinlivan EB, Patton L, Wohl D, Raab-Traub N. Webster-Cyriaque J, et al. Among authors: quinlivan eb. J Infect Dis. 1997 Jun;175(6):1324-32. doi: 10.1086/516463. J Infect Dis. 1997. PMID: 9180170

10

Longitudinal sero-reactivity to human herpesvirus 8 (KSHV) in the Swiss HIV Cohort 4.7 years before KS.

Quinlivan EB, Wang RX, Stewart PW, Kolmoltri C, Regamey N, Erb P, Vernazza PL; Swiss HIV Cohort Study. Quinlivan EB, et al. J Med Virol. 2001 Jun;64(2):157-66. doi: 10.1002/jmv.1031. J Med Virol. 2001. PMID: 11360248

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

78 results

Search Page

Filters